Fluxomics as a methodological tool for designing drugs
https://doi.org/10.52419/issn2782-6252.2023.1.72
Abstract
This article defines fluxomics as a biomedical science and an area of metabolic research, which is used as a methodological tool for the design of medicinal substances, including for veterinary use.
The scientific novelty of the publication lies in the complexity of the ongoing review of existing research in the field of the latest methods of designing pharmaceutical substances (including those based on digital transformation), such as the study of cell flux, with a description of the main methodological approaches and principles. The main author's hypothesis of this study is the possibility of identifying the most promising approaches in terms of veterinary pharmacology for their further possible introduction into industry practice.
The purpose of the review is to substantiate the priority use of the Fluxomics methodology as a stage in the development of new drugs for veterinary use with the study of the main methodological approaches.
The information retrieval methodology was based on such general scientific methods of cognition as: a review of specialized search engines and databases of scientific and research data (Scopus, WoS, PubMed) over the past 10 years, of which the most informative ones were selected, analysis of the identified results, and their comparison by relevance.
As a result of the analysis, the role of fluxomics in the structure of "ohmic" sciences was revealed, the main concepts that determine the development of fluxomics as a set of algorithms for the study of metabolic networks, analytical and instrumental methods for implementing fluxomic models were considered, the main problems and prospects for using this methodological apparatus in the context of designing and further validation of drug candidate substances.
About the Author
V. S. PonamarevRussian Federation
PhD in Veterinary Sciences
References
1. Nielsen, J. Systems biology of metabolism / J. Nielsen // Annual Review of Biochemistry. - 2017. - Vol. 86. – P. 245-275. – DOI 10.1146/annurev-biochem-061516-044757. – EDN ZGIJLR.
2. Cascante, M. Fluxomics / M. Cascante, A. Benito, I. Marín De Mas [et al.] // A Systems Biology Approach to Study Metabolic Syndrome, 2014. - P. 237-250. – DOI 10.1007/978-3-319-01008-3_12. – EDN WQPCJP.
3. Emwas, A. H. Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways / A. H. Emwas, K. Szczepski, M. Jaremko [et al.] // Frontiers in Pharmacology. - 2022. - Vol. 13, no. Jan. – P. 805782. – DOI 10.3389/fphar.2022.805782. – EDN HKPNZM.
4. Abdullaev, A. A. Metabolic approaches in the study of cardiovascular diseases / A. A. Abdullaev, G. Zh. Abdullaeva, Kh. F. Yusupova // Eurasian Journal of Cardiology. - 2021. - No. 1 (34). - S. 106-117. – DOI 10.38109/2225-1685-2021-1-106-117. – EDN TSESKB.
5. Emwas A-, Szczepski K, Al-Younis I, Lachowicz JI and Jaremko M (2022) Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways. front. Pharmacol. 13:805782. doi:10.3389/fphar.2022.805782
6. Violante, S. Stable isotope tracers for metabolic pathway analysis / S. Violante, M. Berisa, J. R. Cross, T. H. Thomas // Methods in Molecular Biology. - 2019. - Vol. 1978. - P. 269- 283. – DOI 10.1007/978-1-4939-9236-2_17. – EDN JMXRFN.
7. Wolak, J. Noninvasive fluxomics in mammalsoscopy by nuclear magnetic resonance spectr / J. Wolak, K. RahimiKeshari, R. E. Jeffries [et al.] // . - 2012. - Vol. 17. - P. 321-392. – DOI 10.1007/978-1-61779-618-0_11. – EDN ROUDEB.
8. Millard, P. Impact of kinetic isotope effects in isotopic studies of metabolic systems / P. Millard, P. Mendes, J. C. Portais // . – 2015. – Vol. 9, No. 1. – P. 64. – DOI 10.1186/s12918-015-0213-8. – EDN XTVAKL.
9. Sen, P. Kinetic modelling of phospholipid synthesis in Plasmodium knowlesi unravels crucial steps and relative importance of multiple pathways / P. Sen, H. J. Vial, O. Radulescu // BMC Systems Biology. – 2013. – Vol. 7. – P. 123. – DOI 10.1186/1752-0509-7-123. – EDN YVSXWL.
Review
For citations:
Ponamarev V.S. Fluxomics as a methodological tool for designing drugs. Legal regulation in veterinary medicine. 2023;(1):72-75. (In Russ.) https://doi.org/10.52419/issn2782-6252.2023.1.72